The Cardiovascular Drug Delivery section of Frontiers in Drug Delivery publishes high-quality reports on basic, translational and clinical research across this expanding part of cardiovascular medicine that addresses the targeted application of drug delivery systems in patients with cardiovascular disease.Read More
The Cardiovascular Drug Delivery section of Frontiers in Drug Delivery publishes high-quality reports on basic, translational and clinical research across this expanding part of cardiovascular medicine that addresses the targeted application of drug delivery systems in patients with cardiovascular disease. The advances in this scientific field will have an enormous impact on targeted drug delivery techniques and on personalized tools to improve allocation of preventive therapy.
Areas covered by this interdisciplinary section include, but are not limited to:
Drug delivery to cardio-, cerebro-, retino-, and renovascular disorders
Thrombolytic drug delivery systems
Drug-releasing vascular prostheses
Cardiovascular risks related to intravascular nanomedicines
Immuno-safety of drug delivery systems
Drug-target cell interaction modelling
All studies must contribute insights into cardiovascular drug delivery and cardiovascular disease processes. Reports dealing solely with diagnostics/imaging do not fall within the scope of this section and should be submitted to more specialized journals, e.g. Frontiers in Cardiovascular Medicine (Cardiovascular Imaging Section), or Frontiers in Medical Technology.
Indexed in: CLOCKSS, CrossRef, Google Scholar, OpenAIRE
PMCID: all published articles receive a PMCID
Cardiovascular Drug Delivery welcomes submissions of the following article types: Brief Research Report, Case Report, Clinical Trial, Community Case Study, Data Report, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Policy and Practice Reviews, Policy Brief, Protocols, Review, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Cardiovascular Drug Delivery, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact email@example.com
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact firstname.lastname@example.org